Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute?
A public economics framework is used to consider how pharmaceuticals should be priced when at least some of the research and development incentive comes from sales revenues. Familiar techniques of public finance are used to relax some of the restri...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Language: | English en_US |
| Published: |
Published by Oxford University Press on behalf of the World Bank
2014
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2005/01/17747581/financing-pharmaceutical-innovation-much-poor-countries-contribute http://hdl.handle.net/10986/16481 |